ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.

By S. Hunt, David W. Baker, Marshall H. Chin, Michael P. Cinquegrani, A. Feldman, Gary S. Francis, Theodore G. Ganiats, Sidney Goldstein, G. Gregoratos, Mariell Jessup and 13 more. The Journal of Heart and Lung Transplantation, 2002

653 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/87e2f3250b6e5630d1332019c03b27b9f931cc06

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. M. Redfield
3. Steven Jacobsen
4. R. Rodeheffer
5. Douglas W. Mahoney
6. S. Anker
7. Gerasimos Filippatos
8. Joseph S. Alpert

Citations in the corpus

• Universal Definition and Classification of Heart Failure. (2021, background): “The ACC/AHA stages are categorized as Stage A, patients at high risk for HF but without structural heart disease or symptoms of HF; Stage B, structural heart disease but without signs or symptoms of HF; Stage C, structural heart disease with prior or current symptoms of HF; and Stage D, refractory H”
• Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. (2003, background): “Prevention of CHF through the treatment of preclinical systolic dysfunction is recommended in CHF guidelines.(6) Although we acknowledge the lack of therapies proven to modify disease course in diastolic CHF, several clinical trials are underway.”